Products

What will AGI do for Bamipine salicylate?

This classification denotes a histamine-1 receptor antagonist C19H24N2.C7H6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2D7769LY0R, chemically known as benzoic acid, 2-hydroxy-, compd. with 1-methyl-n-phenyl-n-(phenylmethyl)-4-piperidinamine, but more generally known as bamipine salicylate, which bears US NIH Compound Identifier 6453348. European Medicines Agency schedules Bamipine salicylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12982MIG. Most nations, for tariff and trade purposes, schedule bamipine salicylate under HS 29333999 and SITC 51574. As of Q4 2014, BAMIPINE SALICYLATE remains US FDA's Preferred Term for this commodity. SMILES: CN1CCC(CC1)N(CC2CCCCC2)C3CCCCC3.C1CCC(C(C1)C(=O)O)O.